F. Zeevat

Faculty of Medical Sciences

Telephone:

E-mail:

f.zeevat umcg.nl

ORCID Research Portal

Publications

Cost-effectiveness Analysis of COVID-19 mRNA XBB.1.5 Fall 2023 Vaccination in the Netherlands

Zeevat, F., van der Pol, S., Westra, T., Beck, E., Postma, M. J. & Boersma, C., Mar-2025, In: Advances in therapy. 42, 3, p. 1550-1569 20 p., e13174.

Research output: Contribution to journal › Article › Academic › peer-review

Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations

van der Pol, S., Zeevat, F., Postma, M. J. & Boersma, C., 31-May-2024, In: Vaccine. 42, 15, p. 3429-3436 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands: a Holistic Approach

Zeevat, F., Simons, J. J. M., Westra, T. A., Wilschut, J. C., Boersma, C. & Postma, M. J., Mar-2024, In: Infectious Diseases and Therapy. 13, p. 481–499 19 p.

Research output: Contribution to journal › Article › Academic › peer-review

Assessment of vaccination policies from a health economic perspective: opportunities and emerging foci

Zeevat, F., 2023, [Groningen]: University of Groningen. 218 p.

Research output: Thesis › Thesis fully internal (DIV)

Reducing Hospital Capacity Needs for Seasonal Respiratory Infections: The Case of Switching to High-Dose Influenza Vaccine for Dutch Older Adults

Zeevat, F., Wilschut, J. C., Boersma, C. & Postma, M. J., Apr-2023, In: Value in Health. 26, 4, p. 461-464 5 p.

Research output: Contribution to journal › Article › Academic › peer-review

Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom

RESCEU Investigators, Zeevat, F., Luttjeboer, J., Paulissen, J. H. J., van der Schans, J., Beutels, P., Boersma, C. & Postma, M. J., 12-Aug-2022, In: The Journal of Infectious Diseases. 226, 1, p. S102-S109 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

Reply to Anglemyer et al

Zeevat, F., Boersma, C. & Postma, M., 1-May-2022, In: Journal of infectious diseases. 225, 9, p. 1682-1682 1 p., 621.

Research output: Contribution to journal › Letter › Academic › peer-review

Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program

Zeevat, F., Crepey, P., Dolk, F. C. K., Postma, A. J., Breeveld-Dwarkasing, V. N. A. & Postma, M. J., Jan-2021, In: Value in Health. 24, 1, p. 3-10 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity Lost

Zeevat, F., Dvortsin, E., Wondimu, A., Wilschut, J. C., Boersma, C. & Postma, M. J., 10-Feb-2021, In: Vaccines. 9, 2, 14 p., 144.

Research output: Contribution to journal › Article › Academic › peer-review

Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council's advice

Zeevat, F., van der Schans, J., Boersma, W. G., Boersma, C. & Postma, M. J., Oct-2019, In: Vaccine. 37, 43, p. 6282-6284 3 p.

Research output: Contribution to journal › Article › Academic › peer-review

All (13) publications

View full research profile